Archives

by in
Entry Author Date Location
RXi, EyeGate Team Up 09/22/10 Boston
Dicerna Pharma Gets $25M Boost to Develop Next-Gen Gene Silencing Drugs 08/11/10 Boston
New Startup ViThera Labs Aims “Weaponized” Bacteria Drugs at Gut Diseases 08/10/10 Boston
$5M Debt Deal for Dicerna Pharma 06/30/10 Boston
Former J&J Group Chairman’s Firm Backs BIND Biosciences in $12.4M Round 06/29/10 Boston
Doug Fambrough Reduces Role at Oxford Bioscience Partners, Becomes CEO of Portfolio Company Dicerna Pharma 05/06/10 Boston
Avila Gets Leukemia & Lymphoma Society Funding, Dicerna Unites with Ipsen, Rhythmia to Test Heart Mapping Technology, Amag Licenses to Takeda, & More Boston-Area Life Sciences News 04/02/10 Boston
MDRNA and Cequent Pharma in $46M Merger Deal 04/01/10 Seattle
Novell Turns Down Buyout Offer, Alnylam Pulls In $20M from Takeda, $16M Stock Deal Goes to RXi, & More Boston-Area Deals News 03/24/10 Boston
The Decade’s Most Important Biomedical Discovery 12/18/09 Boston
Nobel Laureate from Caltech, RNAi Leader To Headline Xconomy San Diego Event on Monday 12/09/09 San Diego
Mersana Therapeutics Advancing Anti-Tumor Treatment with Novel Drug-Delivery Technology 12/08/09 Boston
Alnylam Eyes RNAi for Manufacturing Drugs 11/12/09 Boston
Alnylam Chief Foresees Another Gene-Silencing Spin-Off, and More News Tidbits from Boston’s MassBio Investors Forum 10/07/09 Boston
Alnylam and Tekmira Seek New Ways to Deliver RNAi Drugs Deep in the Body 08/06/09 Boston
Replacing Phil Sharp Will Be Up to Biogen’s Board 07/20/09 Boston
Novartis Extends Alnylam Deal 07/17/09 Boston
Isis, Alnylam to Collaborate on Single-Stranded RNA Drugs; Deal Could Add Up to $31 Million to Isis’ Coffers 04/29/09 San Diego
Cleaner Water Through Biotech? 349Q Kills Water-Borne Microbes with RNAi 04/27/09 Boston
Alnylam to Receive European Patent 04/20/09 Boston
Traversa Gets $5M 04/02/09 San Diego
Intellectual Ventures Inks India Deal, Ontela Teams with T-Mobile, MDRNA Nabs $7.25M, & More Seattle-Area Deals News 03/24/09 Seattle
Aura Biosciences Aims to Develop “Ballistic Missile” Drug to Beat Pancreatic Cancer, Deliver RNAi Therapies 03/12/09 Boston
Regulus Therapeutics Follows Through on Fundraising, Independence Plans 03/04/09 San Diego
RXi to Sell up to $25M in Stock 02/05/09 Boston
Alnylam, Cubist Will Cooperate on RNAi Drug for Lung Infections 01/09/09 Boston
Another Next-Generation RNAi Startup Emerges, Makes Big Claims About Its Ability to Silence Bad Genes 12/18/08 Boston
Mass Life Sciences Center Attracts J&J Matching Funds, Awards $3.7M in Industry-Academic Grants 12/16/08 Boston
Alnylam Forms UCSF Collaboration 12/11/08 Boston
Alnylam Buys More RNAi Patents From Nucleonics 12/08/08 Boston
Page 2 of 3 « previous page · next page »
    

Xconomy Events Across the Network

XSITE 2012: The Xconomy Summit on Innovation, Technology & Entrepreneurship

Boston · 6/14/12
8:30 am - 5:00 pm

More Xconomy Events

Xconomy’s Most Popular

  1. ASCO Preview: Eight Cancer Drugs to Watch at the Big Show
  2. Biotech IPOs Start to Show Some Modest Signs of Life
  3. Hey, Silicon Valley: Wake Up and Smell the Robots
  4. From MIT Entrepreneur to Tea Party Leader: The Thomas Massie Story
  5. Announcing Xconomy’s Napa Summit: Keeping America Growing

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.